The IPAB (Independent Payment Advisory Board) was created by the ACA (see sections 3403 and 10320 of the ACA for the legislative language that established the IPAB). It would have been a 15-member board, with the board members appointed by the President and confirmed by the Senate.
The idea was that if Medicare per-capita spending growth were to exceed a target amount, the IPAB would have proposed evidence-based recommendations to reduce Medicare spending growth. But Medicare spending growth has been particularly low since the ACA was enacted, and nobody was ever appointed to the IPAB. The program was repealed in early 2018 as part of the budget act.
The President would have been required to consult with Congressional leaders for at least 12 of the 15 appointments, and the Senate would have had to confirm all of the appointees. IPAB members would have been required to possess expertise in health care, economics, medical research, health coverage and/or third-party administration of employer health plans.
And while medical providers could have been on the board, no more than seven of the 15 members could have been providers. In addition, board members would have had to demonstrate that they didn’t have conflicts of interest, and would have had to give up any other jobs that they previously held, as serving on the IPAB would have been a full-time federal position.
If Medicare per-capita spending growth exceeded a target amount, the IPAB would have been tasked with drafting recommendations for reducing spending growth. Once the recommendations were made, Congress could have voted to implement different cost containment measures that achieved at least as much savings as the IPAB recommendations. But they would have needed a three-fifths majority in the Senate in order to ignore the issue altogether. So the IPAB wouldn’t have had the final say in the matter, but neither could their recommendations have simply fallen on deaf ears.
The Medicare Payment Advisory Commission (MedPAC) is a more stripped-down version of the IPAB, and has been in place for more than two decades. But unlike the IPAB, MedPAC’s recommendations can be — and routinely are — ignored by Congress. In order to ignore recommendations from the IPAB, Congress would need a supermajority vote. And if Congress were to fail to pass their own legislation to contain Medicare spending growth, the IPAB’s recommendations would have automatically taken effect.
The text of the ACA specifically notes that the IPAB’s recommendations could not have included increasing Medicare payroll taxes or beneficiary premiums, nor could they have recommended any sort of rationing or increases in beneficiary cost-sharing. But cuts to provider reimbursements would have been allowed as of 2019, which pitted most provider groups against the IPAB.
The IPAB was controversial from the start. It was envisioned as a concrete step towards containing Medicare spending growth, but critics called it a “death panel,” charging that it would effectively result in rationing—despite the ACA’s language preventing direct rationing—and that it would amount to bureaucrats getting between seniors and their health care.
IPAB’s supporters believed that it made sense for a panel of experts using medical evidence to weigh what we should cover and what we should pay for various treatments. But many Americans are wary of “experts” and Republicans are particularly skeptical. Polling shows that when asked about having an independent panel make proposals for Medicare, 59 percent of Republicans expressed a high level of distrust vs. 39 percent of Democrats.
Per-capita Medicare spending growth has been much lower than expected in recent years. Between 2000 and 2010, it averaged 7.4 percent per year. But between 2010 and 2016, it averaged just 1.3 percent per year. As a result, the IPAB cost-containment recommendation process has never been triggered. And as of 2017, it was projected that it still wouldn’t be triggered until 2021 (the ACA allowed for the IPAB process to begin as early as 2014, if Medicare spending growth had exceeded targets at that point).
The board itself has never existed. President Obama never appointed anyone to it, nor did President Trump. So conversations about the IPAB in the early years of ACA implementation were theoretical, rather than practical, as there was no need for the IPAB process to be implemented. But the IPAB remained controversial, even though some fiscal conservatives saw it as a necessity to keep Medicare solvent. Even Democratic lawmakers weren’t particularly fond of it.
Section 52001 of the Bipartisan Budget Act of 2018 repeals the IPAB. The act was signed into law by President Trump on February 9, 2018. As noted above, the IPAB never convened and its process was never triggered, given how low per-capita Medicare spending growth has been since the ACA was enacted. But projections about if and when the IPAB will be triggered are now moot.
Louise Norris is an individual health insurance broker who has been writing about health insurance and health reform since 2006. She has written dozens of opinions and educational pieces about the Affordable Care Act for healthinsurance.org. Her state health exchange updates are regularly cited by media who cover health reform and by other health insurance experts.
Sweeping health reform legislation delivered a long list of provisions focused on health insurance affordability, consumer protections.